IPO-38 (IPO-38), 0.2mg/mL — image 1 of 2

Product details

IPO-38 (IPO-38), 0.2mg/mL

Catalog number BNUB0697-500

Price for BNUB0697-500

Size / count 1x 500 µL

About this product

Recognizes a protein of 14-16 kDa, which is a novel nuclear antigen of proliferating cells. IPO-38 antigen is present in the nuclei of proliferating cells such as Hodgkin's disease and non-Hodgkin's lymphomas, different forms of leukemias, breast and colorectal carcinomas, and PHA-stimulated lymphocytes. It is not expressed in the cells of non-stimulated lymphocytes and granulocytes. IPO-38 may be a useful marker of cell proliferation during monitoring of tumor progression. This antibody is available purified with BSA/azide at 200 ug/mL, or BSA/azide-free at 1 mg/mL.

Specifications

Catalog number: BNUB0697-500
Size / count: 1x 500 µL
Dry ice: No
Hazardous: No
Discontinued: No
CAS Number: 9007-83-4
Synonyms: Not Known
UNSPSC: 41116161
UNSPSC Description: Primary and secondary antibodies for multiple methodology immunostaining detection application
Gene ID: Not Known
NCBI Gene ID: Not Known
UniProt: Not Known
Swiss Prot: Not Known
Host: Mouse
Species Reactivity: Human, Mouse, Rat
Reactivity: IPO-38
Immunogen: Spleen cells of a patient with hairy cell leukemia
Target Antigen: IPO-38
Clonality: Monoclonal
Clone: IPO-38
Type: Primary
Source: Animal
Origin: Animal
Applications: IHC, FFPE (verified)
Field of Research: Cancer, Cell cycle
Positive Control: Raji and PHA-stimulated (>12 hours) human or mouse lymphocytes. Breast and colorectal carcinomas.
Stability: 2 years
Concentration: 0.2 mg/mL
Buffer: PBS, 0.05% BSA, 0.05% azide
Molecular Weight: 14-16 kDa
Shipping Conditions: RT (ND)
Storage Conditions: Stable at room temperature or 37°C (98°F) for 7 days.
Shelf Life: Guaranteed for at least 24 months from date of receipt when stored as recommended
Fragment: IgM, kappa
Species: Mus musculus (mouse), BSA from bovine serum (Bos taurus) or recombinant BSA produced in Chinese hamster ovary cells.
Classification: PBS, 0.05% BSA, 0.05% sodium azide (CAS 26628-22-8)
Conjugate: Purified, with BSA

Frequently Asked Questions

What is the catalog number for IPO-38 (IPO-38), 0.2mg/mL?

The catalog number for IPO-38 (IPO-38), 0.2mg/mL is BNUB0697-500.

What sizes are available for IPO-38 (IPO-38), 0.2mg/mL?

IPO-38 (IPO-38), 0.2mg/mL is available in the following size(s): 1x 500 µL.

Is IPO-38 (IPO-38), 0.2mg/mL in stock?

IPO-38 (IPO-38), 0.2mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures IPO-38 (IPO-38), 0.2mg/mL?

IPO-38 (IPO-38), 0.2mg/mL is manufactured by Biotium.

What is the estimated delivery time for IPO-38 (IPO-38), 0.2mg/mL?

Estimated delivery time for IPO-38 (IPO-38), 0.2mg/mL is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for IPO-38 (IPO-38), 0.2mg/mL?

The safety data sheet for IPO-38 (IPO-38), 0.2mg/mL is available here: https://biotium.com/wp-content/uploads/2018/06/SDS-primary-antibodies.pdf.

What is IPO-38 (IPO-38), 0.2mg/mL used for?

Can I request additional validation data, such as western blot images, for this product?

Additional data may be available on request. Contact our technical support team with the catalogue number and we’ll check what supporting documentation the supplier can provide.

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Is this antibody conjugated?

Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.